Medicare AdvantageBilling CodesMedium impact
MA08.007ay, Medicare Part B vs. Part D Crossover Drugs
Independence Blue Cross·PA · Oncology, Cardiology, Internal Medicine +1 more·Pharmacy
Effective date
Oct 1, 2026
We identified it
Oct 2, 2026
Summary
Independence Blue Cross updated MA08.007ay with new HCPCS codes for furosemide and fluorouracil injections effective 10/01/2026. Three codes were added (J1946, J1947, J9191, J9192), two were deleted (J1941, J9190), and an FDA approval notation was removed from CPT 90616. Billing teams must update their systems to reflect these code changes in Attachments B and E of the policy.
Action Required
By 09/30/2026: Billing team must update the billing system to add HCPCS codes J1946 (furosemide lasix onyu, 1 mg), J1947 (furosemide furoscix, 1 mg), J9191 (fluorouracil avyxa, 10 mg), and J9192 (fluorouracil, 10 mg) to Attachments B and E respectively. Remove HCPCS codes J1941 (furosemide furoscix, 20 mg) from Attachment B and J9190 (fluorouracil 500 mg) from Attachment E. Remove the FDA approval asterisk from CPT 90616 in Attachment C. Verify all code changes are reflected in the practice management system's Medicare Advantage claim submission rules. Notify providers of the deleted codes to prevent incorrect billing. Failure to implement these changes will result in claim denials for services billed with deleted codes.